Esophagus adenocarcinoma
Clinical trials for Esophagus adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Esophagus adenocarcinoma trials appear
Sign up with your email to follow new studies for Esophagus adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Aiming to cure esophageal cancer without the knife
Cure OngoingThis trial is testing whether a combination of the immunotherapy drug durvalumab, chemotherapy, and radiation can completely eliminate early-stage esophageal cancer, potentially making surgery unnecessary. The study enrolls adults with early-stage (cT1 or cT2N0) esophageal adenoc…
Matched conditions: ESOPHAGUS ADENOCARCINOMA
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Cure
Last updated Aug 09, 2026 00:00 UTC
-
Can a Triple-Drug attack slow down stomach cancer?
Disease control OngoingThis phase 2 trial is testing whether a combination of trifluridine/tipiracil (Lonsurf) plus oxaliplatin, with or without the immunotherapy nivolumab, can help people with advanced HER2-negative stomach, esophageal, or gastroesophageal junction cancer. The study compares these co…
Matched conditions: ESOPHAGUS ADENOCARCINOMA
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC